Nivestym Co-pay Assistance
Pfizer
The Nivestym Co-pay Assistance program, offered by Pfizer Oncology Together, helps commercially insured patients cover out-of-pocket expenses, including co-pays or coinsurance, for NIVESTYM® treatment. Eligible patients may pay as little as $0 per treatment, with a maximum benefit of $10,000 per calendar year, and there are no income requirements to qualify. This program is not available to patients enrolled in state- or federally funded prescription insurance programs.
- Covers
- financial assistance
- Max award
- $10,000
- Enrollment cycle
- rolling
Eligibility
Eligible patients must have commercial insurance covering NIVESTYM and cannot be enrolled in government-funded programs like Medicare or Medicaid. There are no income requirements for qualification, but the program excludes cash-paying patients and those in prohibited states.
Apply
Application goes directly to Pfizer. RxCopays does not receive compensation.
Go to application →Status source
Visit PfizerCoPay.com to enroll now
Rare-disease support beyond financial help
This grant covers a rare condition. For specialists, clinical trials, and patient communities, our sister site UniteRare.org has in-depth pages: